Genetic secrets of long-term glioblastoma survivors

por Jovčevska, Ivana
Publicado no Bosn J Basic Med Sci (2019)

Next Generation Sequencing and Machine Learning Technologies Are Painting the Epigenetic Portrait of Glioblastoma

por Jovčevska, Ivana
Publicado no Front Oncol (2020)

The Therapeutic Potential of Nanobodies

por Jovčevska, Ivana, Muyldermans, Serge
Publicado no BioDrugs (2019)

Glioma and glioblastoma - how much do we (not) know?

por JOVČEVSKA, IVANA, KOČEVAR, NINA, KOMEL, RADOVAN
Publicado em 2013

Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy

por Zottel, Alja, Videtič Paska, Alja, Jovčevska, Ivana
Publicado no Materials (Basel) (2019)

Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma

por Šamec, Neja, Zottel, Alja, Videtič Paska, Alja, Jovčevska, Ivana
Publicado no Molecules (2020)

Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs

por Zottel, Alja, Šamec, Neja, Videtič Paska, Alja, Jovčevska, Ivana
Publicado no Cancers (Basel) (2020)

High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas

por Jovčevska, Ivana, Zottel, Alja, Šamec, Neja, Mlakar, Jernej, Sorokin, Maxim, Nikitin, Daniil, Buzdin, Anton A., Komel, Radovan
Publicado no Cancers (Basel) (2019)

Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration

por Zottel, Alja, Jovčevska, Ivana, Šamec, Neja, Mlakar, Jernej, Šribar, Jernej, Križaj, Igor, Skoblar Vidmar, Marija, Komel, Radovan
Publicado no Ther Adv Med Oncol (2020)

Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates

por Vidak, Marko, Jovcevska, Ivana, Samec, Neja, Zottel, Alja, Liovic, Mirjana, Rozman, Damjana, Dzeroski, Saso, Juvan, Peter, Komel, Radovan
Publicado no Int J Mol Sci (2018)

Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting

por Samec, Neja, Jovcevska, Ivana, Stojan, Jure, Zottel, Alja, Liovic, Mirjana, Myers, Michael P., Muyldermans, Serge, Šribar, Jernej, Križaj, Igor, Komel, Radovan
Publicado no Oncotarget (2018)

Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive...

por Jovčevska, Ivana, Zupanec, Neja, Urlep, Žiga, Vranič, Andrej, Matos, Boštjan, Stokin, Clara Limbaeck, Muyldermans, Serge, Myers, Michael P., Buzdin, Anton A., Petrov, Ivan, Komel, Radovan
Publicado no Oncotarget (2017)

Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma

por Sorokin, Maxim, Raevskiy, Mikhail, Zottel, Alja, Šamec, Neja, Skoblar Vidmar, Marija, Matjašič, Alenka, Zupan, Andrej, Mlakar, Jernej, Suntsova, Maria, Kuzmin, Denis V., Buzdin, Anton, Jovčevska, Ivana
Publicado no Cancers (Basel) (2021)

Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles

por Zottel, Alja, Šamec, Neja, Kump, Ana, Dall’Olio, Lucija Raspor, Pužar Dominkuš, Pia, Romih, Rok, Hudoklin, Samo, Mlakar, Jernej, Nikitin, Daniil, Sorokin, Maxim, Buzdin, Anton, Jovčevska, Ivana, Komel, Radovan
Publicado no Int J Mol Sci (2020)

TRIM28 and β-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers

por Jovčevska, Ivana, Zupanec, Neja, Kočevar, Nina, Cesselli, Daniela, Podergajs, Neža, Stokin, Clara Limbaeck, Myers, Michael P., Muyldermans, Serge, Ghassabeh, Gholamreza Hassanzadeh, Motaln, Helena, Ruaro, Maria Elisabetta, Bourkoula, Evgenia, Turnšek, Tamara Lah, Komel, Radovan
Publicado no PLoS One (2014)

Advances in Molecular Genetics of Brain Tumors

Publicado em 2023

Advances in Molecular Genetics of Brain Tumors

Publicado em 2023